Form 4 Tracker
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA

67 insider filings · Latest: Aug 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 5, 2026May 5 8:00 PMDaniell Richard
Proposed Sale
30,000$35.40$1.1M

View →

May 1, 2026May 4 8:02 PMMark SabagSee "Remarks"
Sale
144,180$34.99$5.0M80,760(D)

View →

Apr 30, 2026May 4 8:00 PMChristine FoxEVP, U.S. Commercial
Sale
21,258$35.31$750.6K63,647(D)

View →

May 1, 2026May 4 12:12 PMSabag Mark
Proposed Sale
144,180$34.99$5.0M

View →

Apr 30, 2026Apr 30 8:40 PMChristine Fox
Proposed Sale
21,258$35.31$750.6K

View →

Mar 17, 2026Mar 19 8:01 PMMark SabagSee "Remarks"
Sale
62,102$30.14$1.9M224,940(D)

View →

Mar 17, 2026Mar 17 8:15 PMSabag Mark
Proposed Sale
62,102$30.14$1.9M

View →

Mar 5, 2026Mar 9 8:18 PMRichard D FrancisPresident and CEO
Sale
20,025$31.67$634.2K1,170,639(D)

View →

Mar 5, 2026Mar 9 8:16 PMChristine FoxEVP, U.S. Commercial
Sale
7,924$31.67$250.9K84,905(D)

View →

Mar 5, 2026Mar 9 8:14 PMEric A HughesSee "Remarks"
Sale
9,533$31.67$301.9K107,711(D)

View →

Mar 5, 2026Mar 9 8:12 PMRichard DaniellEVP, Europe Commercial
Sale
17,295$31.67$547.7K85,755(D)

View →

Mar 5, 2026Mar 9 8:10 PMPlacid JoverSee "Remarks"
Sale
14,150$31.67$448.1K6,774(D)

View →

Mar 5, 2026Mar 9 8:09 PMBrian SavageInterim Chief Legal Officer
Sale
1,127$31.67$35.7K10,914(D)

View →

Mar 5, 2026Mar 9 8:05 PMMatthew ShieldsEVP, Global Operations
Sale
17,295$31.67$547.7K9,989(D)

View →

Mar 4, 2026Mar 6 9:19 PMRichard D FrancisPresident and CEO
Sale
23,393$32.46$759.4K1,148,212(D)

View →

Mar 4, 2026Mar 6 9:17 PMRichard DaniellEVP, Europe Commercial
Sale
91,345$32.66$3.0M85,755(D)

View →

Mar 4, 2026Mar 6 9:09 PMEric A HughesSee "Remarks"
Sale
11,277$32.46$366.1K97,590(D)

View →

Mar 4, 2026Mar 6 9:05 PMChristine FoxEVP, U.S. Commercial
Sale
9,098$32.46$295.4K75,010(D)

View →

Mar 4, 2026Mar 6 9:03 PMBrian SavageInterim Chief Legal Officer
Sale
2,675$32.46$86.8K8,461(D)

View →

Mar 5, 2026Mar 5 10:49 PMShields Matthew
Proposed Sale
17,295$31.67$547.7K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 4, 2026Mar 6 9:13 PMMark SabagSee "Remarks"
Option Exercise
52,11337,202(D)

View →

Mar 4, 2026Mar 6 9:11 PMEvan LippmanEVP, Business Development
Grant/Award
27,34727,347(D)

View →

Mar 4, 2026Mar 6 9:09 PMEric A HughesSee "Remarks"
Option Exercise
23,25146,503(D)

View →

Mar 4, 2026Mar 6 9:09 PMEric A HughesSee "Remarks"
Grant/Award
50,64350,643(D)

View →

Mar 4, 2026Mar 6 9:08 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Option Exercise
56,76346,503(D)

View →

Mar 4, 2026Mar 6 9:08 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Grant/Award
53,17553,175(D)

View →

Mar 4, 2026Mar 6 9:05 PMChristine FoxEVP, U.S. Commercial
Option Exercise
20,46140,923(D)

View →

Mar 4, 2026Mar 6 9:05 PMChristine FoxEVP, U.S. Commercial
Grant/Award
50,64350,643(D)

View →

Mar 4, 2026Mar 6 9:03 PMBrian SavageInterim Chief Legal Officer
Option Exercise
8,5107,534(D)

View →

Mar 4, 2026Mar 6 9:03 PMBrian SavageInterim Chief Legal Officer
Grant/Award
11,28011,280(D)

View →

Mar 4, 2026Mar 6 9:01 PMAmir WeissChief Accounting Officer
Grant/Award
11,28011,280(D)

View →

Mar 4, 2026Mar 6 9:01 PMAmir WeissChief Accounting Officer
Option Exercise
16,32911,300(D)

View →

Mar 3, 2026Mar 5 9:11 PMAmir WeissChief Accounting Officer
Option Exercise
5,1795,180(D)

View →

Mar 3, 2026Mar 5 9:09 PMRichard DaniellEVP, Europe Commercial
Option Exercise
203,7280(D)

View →

Mar 3, 2026Mar 5 9:08 PMMark SabagSee "Remarks"
Option Exercise
166,3780(D)

View →

Mar 3, 2026Mar 5 9:06 PMBrian SavageInterim Chief Legal Officer
Option Exercise
3,4613,461(D)

View →

Mar 3, 2026Mar 5 9:05 PMRichard D FrancisPresident and CEO
Option Exercise
958,5460(D)

View →

Mar 3, 2026Mar 5 9:03 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Option Exercise
191,2780(D)

View →

Mar 3, 2026Mar 5 9:01 PMEric A HughesSee "Remarks"
Option Exercise
166,3780(D)

View →

Feb 15, 2026Feb 18 9:01 PMRichard D FrancisPresident and CEO
Option Exercise
781,7660(D)

View →